# ERDERA Clinical Trial Call 2026 (pre-announcement)

**Funder:** ERDERA
**Deadline:** 29 October 2026 (Two-stage call — pre-proposal deadline shown; full-proposal deadline 2027-09-30)
**Consortium:** Required
**Official call:** https://www.era-learn.eu/network-information/networks/rare-diseases/erdera-clinical-trial-call-2026-pre-announcement
**Last updated:** 5 Jul 2026

## Eligibility & scope

ERDERA Clinical Trial Call 2026 (pre-announcement) — joint transnational call by the ERDERA European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating fun

## Summary

The ERDERA Clinical Trial Call 2026 funds transnational research consortia to conduct clinical trials across European member states, with support coming from national and regional funding agencies in participating countries. This joint call requires at least two partners from different countries and is coordinated through the ERDERA European Partnership. The two-stage process opens in October 2026, with pre-proposals due first and full proposals evaluated later in 2027.

## Who should apply

- Research teams with clinical-trial expertise, ready to lead a transnational consortium
- Institutions in ERDERA participating countries with established clinical research capacity
- Consortia with at least two partners from different eligible countries
- Early-phase to late-stage clinical trial projects aligned with national funding priorities

## Key dates

- Pre-proposal deadline: 29 October 2026
- Full-proposal deadline: 30 September 2027 (for shortlisted consortia)
- Two-stage evaluation with written review and potentially interview stage for advanced proposals

## Tips for applicants

- Secure commitment letters from all consortium partners early, ERDERA panels check governance and co-funding alignment before pre-proposal scoring.
- Align your trial design with the funding priorities of your lead funder country; national co-funders have veto power on scope.
- In the pre-proposal, emphasise transnational added value and why a single-country trial would not work, generic multi-site projects score lower.

## Frequently asked questions

### Does ERDERA Clinical Trial Call 2026 require a transnational consortium?

Yes, the call requires at least two partners from different eligible countries within the ERDERA partnership. Single-country applications are not eligible.

### What is the pre-proposal deadline for ERDERA Clinical Trial Call 2026?

The pre-proposal deadline is 29 October 2026. Shortlisted consortia then submit full proposals by 30 September 2027.

### Who funds ERDERA clinical trial projects?

National and regional funding agencies in participating ERDERA member countries jointly fund successful consortia; verify the co-funding agency in your country on the call page.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/erdera-clinical-trial-call-2026-pre-announcement) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).